{"data":{"id":1001,"lang":"en","title":"Scientists Discover Hidden Death Switch in the Brain Driving Alzheimer's Disease","summary":"Heidelberg University researchers found a toxic NMDA-TRPM4 protein complex driving Alzheimer's and slowed it in mice with compound FP802.","category":"science","category_label":"Science","published_at":"2026-03-23T20:02:58Z","updated_at":"2026-03-23T20:02:58Z","url":"https://techtools.cz/tools/news/article/1001-scientists-discover-hidden-death-switch-in-the-brain-driving-alzheimer-s-disease","api_url":"https://techtools.cz/news-api/v1/articles/1001?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/1001.md?lang=en","image_url":"https://www.sciencedaily.com/images/1920/brain-fire-inflammation-dementia-alzheimers.webp","word_count":157,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260323005526.htm","domain":"sciencedaily.com"},{"url":"https://www.miragenews.com/scientists-find-alzheimers-death-switch-in-brain-1642064/","domain":"miragenews.com"}],"translation":{"lang":"cs","id":1036,"title":"Vědci objevili skrytý vypínač smrti v mozku, který pohání Alzheimerovu chorobu","url":"https://techtools.cz/tools/news/clanek/1036-vedci-objevili-skryty-vypinac-smrti-v-mozku-ktery-pohani-alzheimerovu-chorobu","api_url":"https://techtools.cz/news-api/v1/articles/1036?lang=cs"},"content":"Researchers at Heidelberg University have identified a toxic protein complex in the brain that acts as a hidden \"death switch\" fueling Alzheimer's disease. The team, led by Prof. Dr. Hilmar Bading, found that when NMDA receptors pair with TRPM4 ion channels, they form a destructive complex that triggers brain cell death and memory loss — appearing at far higher levels in Alzheimer's-affected brains.\n\nUsing an experimental compound called FP802, the researchers successfully disrupted this toxic interaction in mice. Treated animals showed markedly slowed disease progression, preserved learning and memory, reduced synaptic loss, and significantly less beta-amyloid buildup. \"In Alzheimer's mice treated with the molecule, disease progression was markedly slowed,\" said Dr. Jing Yan, formerly of Bading's team.\n\nUnlike conventional Alzheimer's therapies that target amyloid plaque formation directly, this approach attacks a downstream cellular mechanism — potentially offering a new treatment pathway. The findings, published in Molecular Psychiatry, remain in the preclinical stage, with human clinical trials still years away."}}